In type 1 autoimmune hepatitis, is cirrhosis at presentation or follow-up associated with a poorer outcome? [1]

Hepatology

Volumn 42, Issue 5, 2005, Pages 1237-

  Verma, Sumita ^a   Redeker, Allan ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Rancho Los Amigos Alzheimer's Disease Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNE HEPATITIS; FOLLOW UP; HUMAN; LETTER; LIVER CIRRHOSIS; LIVER FAILURE; LIVER NECROSIS; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SURVIVAL TIME;

FOLLOW-UP STUDIES; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 30944464850     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.20932     Document Type: Letter

References (6)

1. Feld JJ, Dinh H, Arenovich T, Marcus VA, Wanless IR, Heathcote EJ. Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome. HEPATOLOGY 2005;42:53-62.
2. Verma S, Gunuwan B, Mendler M, Govindrajan S, Redeker A. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy. Am J Gastroenterol 2004;99:1510-1516.
3. Czaja AJ. Treatment strategies in autoimmune hepatitis. Clin Liver Dis 2002;6:511-536.
4. Davis GL, Czaja AJ, Ludwig J. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis. Gastroenterol 1984;87:1222-1227.
5. Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gasteroenterol 1996;110:848-857.
6. Adams LA, Lindor KD, Angulo P. The prevalence of autoantibodies and autoimmune hepatitis in patients with non alcoholic fatty liver disease. Am J Gastroenterol 2004;99:1316-1320.